Prospera Financial Services Inc 9 Meters Biopharma, Inc. Transaction History

Prospera Financial Services Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$0.26 - $0.64 $2,080 - $5,120	8,000 Added 40.0%	28,000 $7,000
Q1 2022 May 04, 2022	BUY	$0.52 - $1.0 $1,560 - $3,000	3,000 Added 17.65%	20,000 $12,000
Q4 2021 Feb 10, 2022	SELL	$0.85 - $1.33 $3,400 - $5,320	-4,000 Reduced 19.05%	17,000 $17,000
Q1 2021 May 06, 2021	BUY	$0.84 - $2.16 $5,040 - $12,960	6,000 Added 40.0%	21,000 $24,000
Q3 2020 Nov 04, 2020	BUY	$0.48 - $0.84 $7,200 - $12,600	15,000 New	15,000 $12,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.